Pulmonary Artery Hypertension
Also known as: Pulmonary Arterial Hypertension (CHD) / Arterial Hypertension, Pulmonary / Pulmonary Arterial Hypertention / Pulmonary Arterial Hypertension / Hypertension, Pulmonary Arterial / Hypertension, Pulmonary Artery / Pulmonary Arterial Hypertension (PAH) / PAH / Pulmonary Arterial Hypertension PAH / WHO Group 1 Pulmonary Arterial Hypertension (PAH) / Pulmonary hypertensive arterial disease (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB01240 | Epoprostenol | A vasodilator and platelet aggregation inhibitor used for the management of primary pulmonary hypertension and pulmonary hypertension in patients with heart failure. |
DB08932 | Macitentan | An endothelin receptor antagonist used to manage pulmonary arterial hypertension to delay disease progression. |
DB08931 | Riociguat | A stimulator of soluble guanylate cyclase indicated for the management of persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension. |
DB00203 | Sildenafil | A phosphodiesterase inhibitor used for the treatment of erectile dysfunction. |
DB00820 | Tadalafil | A phosphodiesterase 5 inhibitor used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. |
DB00374 | Treprostinil | A prostacyclin vasodilator for the treatment of pulmonary arterial hypertension to relieve exercise associated symptoms and to prevent clinical deterioration after stopping epoprostenol. |